We are pleased to show the industry how WCCT Global is expanding the industry and improving the way clinical research is conducted from recruitment to completion of study.
Costa Mesa, Ca (PRWEB) June 10, 2013
Contract Research Organization WCCT Global, announced today that they will be attending the 2013 DIA trade show event in Boston, Massachusetts. WCCT Global is very excited this year because they will be discussing their capabilities that have been expanding over the past year in late phase clinical trials. Over the past year WCCT Global has conducted studies spanning from very large phase I NHV to very specific late phase work including hepatic Failure, Hepatitis B, to Multiple Pediatric Studies. WCCT Global has also been involved heavily in ethnobridging studies. WCCT Global has worked very closely with Japanese Pharmaceutical to assist them in merging into the U.S. Market. We will be discussing our process for Asian bridging studies at the 2013 DIA Tradeshow.
Another exciting topic is WCCT Global will be discussing the recruitment process called the RMT. The RMT has been developed to streamline recruitment using the power of social media and online advertisement tactics. The RMT was also developed to be able to manage multi-site recruitment campaigns for sponsors. This allows sponsors the freedom of not having to manage multiple sites’ recruitment efforts but only receive information from one source for all the sites. Talia Nikolao, V.P. of Business Development stated, “We are pleased to show the industry how WCCT Global is expanding the industry and improving the way clinical research is conducted from recruitment to completion of study.” WCCT Global will be at booth number 1543 and will be raffling off many great prizes.
More about WCCT Global
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
To see how WCCT Global can help with you next clinical study or recruitment needs, Click Here